Feasibility Study of Take-Home LAAM Medication - 3
The purpose of this study is to test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Official Title:||Feasibility Study of Take-Home LAAM Medication|
- Drug use
- Increased prosocial behaviors
- Decreased frequency of HIV related behavior
|Study Start Date:||March 1995|
1-Year study, participant will be randomly assigned to one of two groups: One will have the opportunity to earn take-home doses by turning in a designated number of clean urines. Two will not have the opportunity to earn take-home doses. Clinic visits three times per week. Urine sample given at each visit.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000300
|United States, California|
|Friends Research Institute|
|Los Angeles, California, United States, 90025|
|Principal Investigator:||Walter Ling, M.D.||Friends Research Institute, Inc.|